| Patent | Date |
|---|
Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway
Grant 11,359,013 - Freeman , et al. June 14, 2 | 2022-06-14 |
Nkg2d-fc For Immunotherapy
App 20220002382 - Dranoff; Glenn ; et al. | 2022-01-06 |
NKG2D-fc for immunotherapy
Grant 10,865,233 - Dranoff , et al. December 15, 2 | 2020-12-15 |
Compositions And Methods For The Treatment Of Infections And Tumors
App 20200223926 - Ahmed; Rafi ; et al. | 2020-07-16 |
Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (pd-1)
App 20190309065 - Freeman; Gordon ; et al. | 2019-10-10 |
Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway
Grant 10,370,446 - Freeman , et al. | 2019-08-06 |
Compositions And Methods For The Treatment Of Infections And Tumors
App 20190031758 - Ahmed; Rafi ; et al. | 2019-01-31 |
Compositions And Methods For The Treatment Of Infections And Tumors
App 20180155430 - Ahmed; Rafi ; et al. | 2018-06-07 |
Methods For The Treatment Of Infections And Tumors
App 20170146520 - Ahmed; Rafi ; et al. | 2017-05-25 |
Methods for the treatment of infections and tumors
Grant 9,598,491 - Ahmed , et al. March 21, 2 | 2017-03-21 |
Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (pd-1) Pathway
App 20160362492 - Freeman; Gordon ; et al. | 2016-12-15 |
Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway
Grant 9,457,080 - Freeman , et al. October 4, 2 | 2016-10-04 |
Methods For The Treatment Of Infections And Tumors
App 20150239972 - Ahmed; Rafi ; et al. | 2015-08-27 |
Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (pd-1) Pathway
App 20140178370 - Freeman; Gordon ; et al. | 2014-06-26 |
Methods and compositions for the treatment of persistent infections
Grant 8,652,465 - Freeman , et al. February 18, 2 | 2014-02-18 |
Compositions And Methods For The Treatment Of Infections And Tumors
App 20120251537 - Ahmed; Rafi ; et al. | 2012-10-04 |
Nkg2d-fc For Immunotherapy
App 20110311535 - Dranoff; Glenn ; et al. | 2011-12-22 |
T cell regulatory genes associated with immune disease
Grant 7,838,220 - McIntire , et al. November 23, 2 | 2010-11-23 |
Methods For The Treatment Of Infections And Tumors
App 20100151492 - Ahmed; Rafi ; et al. | 2010-06-17 |
Compositions And Methods For The Treatment Of Infections And Tumors
App 20100040614 - Ahmed; Rafi ; et al. | 2010-02-18 |
B7-4 Antibodies and uses therefor
Grant 7,635,757 - Freeman , et al. December 22, 2 | 2009-12-22 |
Methods of identifying compounds that upmodulate T cell activation in the presence of a PD-1 mediated signal
Grant 7,432,059 - Freeman , et al. October 7, 2 | 2008-10-07 |
PD-L2 Molecules: Novel PD-1 Ligands and Uses Therefor
App 20080118511 - Freeman; Gordon ; et al. | 2008-05-22 |
Methods and compositions for the treatment of persistent infections
App 20070122378 - Freeman; Gordon ; et al. | 2007-05-31 |
B7-4 polypeptides and uses therefor
App 20060153841 - Freeman; Gordon ; et al. | 2006-07-13 |
B7-4 polypeptides and uses therefor
Grant 7,038,013 - Freeman , et al. May 2, 2 | 2006-05-02 |
Nucleic acids encoding costimulatory molecule B7-4
Grant 6,936,704 - Freeman , et al. August 30, 2 | 2005-08-30 |
T cell regulatory genes associated with immune disease
App 20050095593 - McIntire, Jennifer Jones ; et al. | 2005-05-05 |
PD-L2 molecules: novel PD-1 ligands and uses therefor
App 20020164600 - Freeman, Gordon ; et al. | 2002-11-07 |
PD-L2 molecules: novel PD-1 ligands and uses therefor
App 20020110836 - Freeman, Gordon ; et al. | 2002-08-15 |
Novel B7-4 molecules and uses therefor
App 20020102651 - Freeman, Gordon ; et al. | 2002-08-01 |
Nucleic Acids Encoding proteins which induce immunological effector cell activation and chemattraction, vectors, and recombinant cells
Grant 5,238,839 - Cantor , et al. August 24, 1 | 1993-08-24 |
| 